林 鵬展

Medicine & Life Sciences

1. Colorectal Neoplasms 100%
2. Neoplasms 42%
3. Survival 29%
4. Mutation 24%
5. Drug Therapy 18%
6. Therapeutics 17%
7. Colonic Neoplasms 17%
8. Deep Learning 16%
9. Leucovorin 15%
10. Hematopoietic Stem Cell Transplantation 14%
11. Genes 12%
12. Rituximab 12%
13. Peripheral Nervous System Diseases 12%
14. Non-Hodgkin's Lymphoma 11%
15. Tegafur 11%
16. Machine Learning 10%
17. Artificial Intelligence 10%
18. Uracil 9%
19. Fluorouracil 9%
20. Capecitabine 9%
21. Cell-Free Nucleic Acids 9%
22. human ERBB2 protein 9%
23. Endometrial Neoplasms 8%
24. Gene Expression 8%
25. Lung Neoplasms 8%
26. Safety 7%
27. Class III Phosphatidylinositol 3-Kinases 7%
28. High-Throughput Nucleotide Sequencing 7%
29. Cetuximab 7%
30. Non-Small Cell Lung Carcinoma 7%
31. Proteins 7%
32. RON protein 6%
33. Mortality 6%
34. Neoplasm Genes 6%
35. MicroRNAs 6%
36. Acquired Factor 8 deficiency 6%
37. Tomography 6%
38. Y-Box-Binding Protein 1 6%
39. interleukin 20 6%
40. ramucirumab 6%